Tamarack Advisers, LP Buys Quest Diagnostics Inc, Pacira BioSciences Inc, Haemonetics Corp, Sells Nevro Corp, Portola Pharmaceuticals Inc, Lantheus Holdings Inc

• New Purchases: DGX, HAE, ZBH, O2T,
• Added Positions: PCRX, BIO, ATRC, CMD, MDRX, HOLX, CORV, RIGL, STRM,
• Reduced Positions: NVRO, PTLA, LNTH, SRCL,
• Sold Out: ALKS, SCI, ISEE, OBLN, TMO, VSI,

For the details of Tamarack Advisers, LP's stock buys and sells, go to https://www.gurufocus.com/guru/tamarack+advisers%2C+lp/current-portfolio/portfolioportfolio

1. Allscripts Healthcare Solutions Inc (MDRX) - 3,925,000 shares, 16.46% of the total portfolio. Shares added by 10.56%
2. Bio-Rad Laboratories Inc (BIO) - 100,000 shares, 11.13% of the total portfolio. Shares added by 53.85%
3. Pacira BioSciences Inc (PCRX) - 625,000 shares, 9.73% of the total portfolio. Shares added by 95.31%
4. Stericycle Inc (SRCL) - 475,000 shares, 8.05% of the total portfolio. Shares reduced by 6.86%
5. AtriCure Inc (ATRC) - 675,000 shares, 7.63% of the total portfolio. Shares added by 58.82%

Tamarack Advisers, LP initiated holding in Quest Diagnostics Inc. The purchase prices were between $85.18 and $101.94, with an estimated average price of $95.97. The stock is now traded at around $100.30. The impact to a portfolio due to this purchase was 6.97%. The holding were 188,900 shares as of .

Tamarack Advisers, LP initiated holding in Haemonetics Corp. The purchase prices were between $81.74 and $120.34, with an estimated average price of $98.18. The stock is now traded at around $133.18. The impact to a portfolio due to this purchase was 4.34%. The holding were 100,000 shares as of .

Tamarack Advisers, LP initiated holding in Zimmer Biomet Holdings Inc. The purchase prices were between $112.14 and $128.84, with an estimated average price of $120.53. The stock is now traded at around $138.45. The impact to a portfolio due to this purchase was 3.91%. The holding were 90,000 shares as of .

Tamarack Advisers, LP initiated holding in IVERIC bio Inc. The purchase prices were between $1.04 and $1.37, with an estimated average price of $1.22. The stock is now traded at around $1.02. The impact to a portfolio due to this purchase was 1.34%. The holding were 3,000,000 shares as of .

Tamarack Advisers, LP added to a holding in Pacira BioSciences Inc by 95.31%. The purchase prices were between $36.57 and $47.97, with an estimated average price of $42.38. The stock is now traded at around $40.39. The impact to a portfolio due to this purchase was 4.75%. The holding were 625,000 shares as of .

Tamarack Advisers, LP added to a holding in Bio-Rad Laboratories Inc by 53.85%. The purchase prices were between $286.93 and $312.59, with an estimated average price of $299.26. The stock is now traded at around $319.27. The impact to a portfolio due to this purchase was 3.9%. The holding were 100,000 shares as of .

Tamarack Advisers, LP added to a holding in AtriCure Inc by 58.82%. The purchase prices were between $26.85 and $30.74, with an estimated average price of $29.17. The stock is now traded at around $30.62. The impact to a portfolio due to this purchase was 2.83%. The holding were 675,000 shares as of .

Tamarack Advisers, LP added to a holding in Cantel Medical Corp by 283.33%. The purchase prices were between $64.3 and $80.64, with an estimated average price of $70.2. The stock is now traded at around $89.08. The impact to a portfolio due to this purchase was 2.42%. The holding were 115,000 shares as of .

Tamarack Advisers, LP added to a holding in Hologic Inc by 22.22%. The purchase prices were between $43 and $49.21, with an estimated average price of $46.17. The stock is now traded at around $49.57. The impact to a portfolio due to this purchase was 0.85%. The holding were 275,000 shares as of .

Tamarack Advisers, LP added to a holding in Correvio Pharma Corp by 39.58%. The purchase prices were between $2.15 and $3.14, with an estimated average price of $2.55. The stock is now traded at around $1.72. The impact to a portfolio due to this purchase was 0.76%. The holding were 3,350,000 shares as of .

Tamarack Advisers, LP sold out a holding in Alkermes PLC. The sale prices were between $21.47 and $37.33, with an estimated average price of $27.46.

Tamarack Advisers, LP sold out a holding in Service Corp International. The sale prices were between $40.45 and $46.78, with an estimated average price of $43.14.

Tamarack Advisers, LP sold out a holding in IVERIC bio Inc. The sale prices were between $1.21 and $1.48, with an estimated average price of $1.37.

Tamarack Advisers, LP sold out a holding in Obalon Therapeutics Inc. The sale prices were between $3.85 and $15.8, with an estimated average price of $6.95.

Tamarack Advisers, LP sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $257.51 and $295.55, with an estimated average price of $275.13.

Tamarack Advisers, LP sold out a holding in Vitamin Shoppe Inc. The sale prices were between $3.6 and $7.24, with an estimated average price of $5.17.